TickerFacts.

Madrigal Pharmaceuticals, Inc. (MDGL): Revenue

Annual figures by period end, from SEC filings.

$958.40M
Year ended 2025-12-31
$1.28B
Trailing 12 months to 2026-06-30
2012-12-31: $147.0K2017-12-31: $02018-12-31: $02019-12-31: $02020-12-31: $02021-12-31: $02022-12-31: $02023-12-31: $02024-12-31: $180.13M2025-12-31: $958.40M$958.40M
2012-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$958.40M+432.1%2026-02-19, From 2025-01-01
2024-12-31$180.13Mn/a2026-02-19, From 2024-01-01
2023-12-31$0n/a2026-02-19, From 2023-01-01
2022-12-31$0n/a2025-02-26, From 2022-01-01
2021-12-31$0n/a2024-02-28, From 2021-01-01
2020-12-31$0n/a2022-02-24, From 2020-01-01
2019-12-31$0n/a2022-02-24, From 2019-01-01
2018-12-31$0n/a2021-02-25, From 2018-01-01
2017-12-31$0n/a2020-02-26, From 2017-01-01
No annual figure between 2012-12-31 and 2017-12-31.
2012-12-31$147.0Kn/a2015-03-12, From 2012-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Madrigal Pharmaceuticals, Inc. (MDGL)2025-12-31$958.40M+432.1%
Ionis Pharmaceuticals Inc (IONS)2025-12-31$943.71M+33.8%
ANI Pharmaceuticals Inc (ANIP)2025-12-31$883.37M+43.8%
Harmony Biosciences Holdings, Inc. (HRMY)2025-12-31$868.45M+21.5%
Acadia Pharmaceuticals Inc (ACAD)2025-12-31$1.07B+11.9%
Prestige Consumer Healthcare Inc. (PBH)2026-03-31$1.09B-4.3%
Arrowhead Pharmaceuticals, Inc. (ARWR)2025-09-30$829.45Mn/m
Collegium Pharmaceutical, Inc (COLL)2025-12-31$780.57M+23.6%
Corcept Therapeutics Inc (CORT)2025-12-31$761.41M+12.8%

Compare MDGL, IONS, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗